Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOTHYROXINE Cause Product packaging quantity issue? 50 Reports in FDA Database

Thyroid Balance & Feminine Wellness

Thyrafemme Balance — 14 gentle ingredients for energy, mood & hormonal harmony.

Discover Thyrafemme

According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Product packaging quantity issue have been filed in association with LEVOTHYROXINE (LEVOTHYROXINE SODIUM). This represents 0.1% of all adverse event reports for LEVOTHYROXINE.

50
Reports of Product packaging quantity issue with LEVOTHYROXINE
0.1%
of all LEVOTHYROXINE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Product packaging quantity issue From LEVOTHYROXINE?

Of the 50 reports, 3 (6.0%) required hospitalization, and 1 (2.0%) were considered life-threatening.

Is Product packaging quantity issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOTHYROXINE. However, 50 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOTHYROXINE Cause?

Fatigue (10,494) Headache (6,425) Insomnia (4,663) Drug ineffective (4,556) Alopecia (4,491) Weight increased (4,130) Nausea (4,013) Palpitations (3,825) Dizziness (3,761) Asthenia (3,694)

What Other Drugs Cause Product packaging quantity issue?

LEUPROLIDE (523) ALBUTEROL (431) BUDESONIDE\FORMOTEROL (301) FENTANYL (286) BUPRENORPHINE (225) CYCLOSPORINE (206) ESTRADIOL (201) BIMATOPROST (177) RIVAROXABAN (174) EXENATIDE (154)

Which LEVOTHYROXINE Alternatives Have Lower Product packaging quantity issue Risk?

LEVOTHYROXINE vs LEVOTHYROXINE\LEVOTHYROXINE LEVOTHYROXINE vs LEVOTHYROXINE\LIOTHYRONINE LEVOTHYROXINE vs LEVOXYL LEVOTHYROXINE vs LEXAPRO LEVOTHYROXINE vs LEXISCAN

Related Pages

LEVOTHYROXINE Full Profile All Product packaging quantity issue Reports All Drugs Causing Product packaging quantity issue LEVOTHYROXINE Demographics